Culture and Expansion Protocols of Organoids
GUIDELINE
Organoids are a complex collection of cells grown in a three-dimensional (3D) medium, which are derived from embryonic stem cells (ESC), induced pluripotent stem cells (iPSC), or adult stem cells (ASC). Organoids are passaged with a combination of mechanical and enzymatic dissociation. Organoids are typically passaged on a consistent regular schedule driven by size or indicators of differentiation such as the accumulation of debris within the lumen of the organoid.
METHODS
- Warm complete medium to room temperature. Keep basal medium at 4°C (on ice). Thaw ECM at 4°C and dilute if required.
- Place desired culture vessels in a 37°C incubator to warm for at least 60 min.
- Aspirate and discard spent medium from the culture vessel without disturbing the domes. Avoid any floating domes while aspirating the medium.
- Using a cell lifter, scrape attached domes from the surface of the plate to the bottom or corner of the vessel. Add a small volume basal medium to each well containing detached domes to facilitate a subsequent transfer.
- Using a pipettor or 5-ml serological pipet pre-wetted with cold basal medium, transfer the "mass" of detached domes plus any medium to an empty conical tube. Using a P1000 pipet tip pre-wetted with cold basal medium, pipet organoid/ECM/medium mixture up and down 20 to 30 times to fully disrupt the domes.
- After mechanical dissociation, fill tube(s) to their maximum volume with the cold basal medium. Centrifuge suspension to pellet. Carefully aspirate supernatant and discard without disturbing the organoid pellet.
- Re-suspend cell pellet in ECM at the desired volume. If necessary, dissociated organoids from multiple tubes can be pooled. With a pipettor, pipet up and down 20 to 30 times to mix or until completely re-suspended. Do not introduce bubbles.
- Remove the culture vessel from the incubator and place it in the BSC.
- Using a pipettor, aspirate and then dispense the proper volume of ECM/organoid suspension in the form of 10 to 15 μl droplets evenly distributed across the culture vessel surface. When seeding 6-well plates, aspirate 100 μl and seed a single well at a time. When seeding larger vessels (eg, 10-cm2 dishes), aspirate 200 μl at a time.
- Immediately cover the vessel with a lid and carefully invert without disturbing the domes.
- Transfer the vessel (while inverted) to a 37°C cell culture incubator. Leave the vessel undisturbed for 15 to 30 min to allow the ECM to polymerize.
- Return the vessel to the BSC and return to the normal orientation.
- Carefully add room temperature complete medium without disturbing the domes.
- Return the plate to the incubator.
- Maintain cells by performing medium changes every 2 to 3 days and passaging as required (every 7 to 14 days, depending on the model).
Creative Bioarray Relevant Recommendations
- Creative Bioarray developed a protocol that can differentiate brain organoids from iPSCs. We also provide a characterization of iPSC-derived organoids using immunocytochemistry and multi-electrode array (MEA).
NOTES
- Inverting the plate facilitates dome formation and reduces the likelihood that dissociated organoids will sink to the bottom of the dome before complete polymerization.
- Immediately before seeding, pipet up and down to ensure a homogenous solution. When seeding large volumes of ECM/suspension this mixing should be performed periodically. Do not introduce bubbles. Do not allow the droplets to touch each other or the walls of the well. Work rapidly. Droplets should remain separated and as raised domes.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Quantification of Cytokines
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- What are the Differences Between M1 and M2 Macrophages?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Human Primary Cells: Definition, Assay, Applications
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- IL-12 Family Cytokines and Their Immune Functions
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Eliminate Mycoplasma From Cell Cultures?
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Cell-Based High-Throughput Screening Techniques
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Cell Immortalization Step by Step
- Adherent and Suspension Cell Culture
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- What Are CAR T Cells?
- Cell Viability, Proliferation and Cytotoxicity Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Immunogenicity Testing: ELISA and MSD Assays
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- Eosinophils vs. Basophils vs. Neutrophils
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Optimization Strategies of Cell-Based Assays
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Role of Cell-Based Assays in Drug Discovery and Development
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Immunogenicity Testing: ELISA and MSD Assays
- Understanding Immunogenicity Assays: A Comprehensive Guide
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
-
Histology
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Troubleshooting in Fluorescent Staining
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- Tips for Choosing the Right Protease Inhibitor
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Multiple Animal Tissue Arrays
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Mitochondrial Staining
- Guides for Live Cell Imaging Dyes
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Modern Histological Techniques
- Multiplexing Immunohistochemistry
- What You Must Know About Neuroscience IHC?
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- From Specimen to Slide: Core Methods in Histological Practice
- Serum vs. Plasma
-
Exosome
- Emerging Technologies and Methodologies for Exosome Research
- How to characterize exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- How to Apply Exosomes in Clinical?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosomes as Emerging Biomarker Tools for Diseases
- Techniques for Exosome Quantification
- How to Perform Targeted Modification of Exosomes?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- How to Enhancement Exosome Production?
- The Role of Exosomes in Cancer
- Unraveling Biogenesis and Composition of Exosomes
- What's the Potential of PELN in Disease Treatment?
- How to Label Exosomes?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
-
ISH/FISH
- ISH probe labeling method
- Multiple Approaches to Karyotyping
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- What are the Differences between FISH, aCGH, and NGS?
- CARD-FISH: Illuminating Microbial Diversity
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- In Situ Hybridization Probes
- Small RNA Detection by ISH Methods
- Comparative Genomic Hybridization and Its Applications
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- How to Use FISH in Hematologic Neoplasms?
- What Is the Use of FISH in Solid Tumors?
- FISH Tips and Troubleshooting
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Telomere Length Measurement Methods
- What Types of Multicolor FISH Probe Sets Are Available?
- Different Types of FISH Probes for Oncology Research
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Key Considerations in Toxicokinetic
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- Key Factors Influencing Brain Distribution of Drugs
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Overview of In Vitro Permeability Assays
- Organ-on-a-Chip Systems for Drug Screening
- Experimental Methods for Identifying Drug-Drug Interactions
- Traditional vs. Novel Drug Delivery Methods
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- Physical and Chemical Properties of Drugs and Calculations
- How to Conduct a Bioavailability Assessment?
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Unraveling the Role of hERG Channels in Drug Safety
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics of Therapeutic Peptides
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- How Are Biomarkers Validated in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- When Should You Introduce ADME Tox Testing in Drug Development?
- How Can You Optimize Drug Toxicity Assessment?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- What Are Biomarkers in Drug Discovery?
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Troubleshooting Common Issues in Drug Toxicity Testing
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- In Vitro ADME vs In Vivo ADME
- A Complete Guide to CYP Reaction Phenotyping in 2026
- How to Interpret CYP Phenotyping Data
- Reaction Phenotyping vs. Metabolic Stability
- The 8 Types of Drug Toxicity Every Researcher Must Know
- Why Cardiotoxicity Matters in R&D?
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Animal Models of Neurodegenerative Diseases
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Why Oncology Organoids Fail? How to Build Models That Work
- How to Select the Right Preclinical Model for Drug Development
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter

